//]]>

Neurodegenerative Diseases (Record no. 27772)

000 -LEADER
fixed length control field 02258nam a22004575i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310153330.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 101118s2010 gw | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783642167584
978-3-642-16758-4
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS400-431
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.19
Edition number 23
264 #1 -
-- Berlin, Heidelberg :
-- Springer Berlin Heidelberg :
-- Imprint: Springer,
-- 2010.
912 ## -
-- ZDB-2-CMS
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dominguez, Celia.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Neurodegenerative Diseases
Medium [electronic resource] /
Statement of responsibility, etc edited by Celia Dominguez.
250 ## - EDITION STATEMENT
Edition statement First.
300 ## - PHYSICAL DESCRIPTION
Extent XVII, 196 p.
Other physical details online resource.
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE
Title Topics in Medicinal Chemistry,
International Standard Serial Number 1862-2461 ;
Volume number/sequential designation 6
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach -- Phosphodiesterase Inhibition to Target the Synaptic Dysfunction in Alzheimer’s Disease -- Glutamate and Neurodegenerative Disease -- Modulation of the Kynurenine Pathway for the Potential Treatment of Neurodegenerative Diseases -- Spinal Muscular Atrophy: Current Therapeutic Strategies.
520 ## - SUMMARY, ETC.
Summary, etc The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach.- Phosphodiesterase Inhibition to Target the Synaptic Dysfunction in Alzheimer’s Disease.- Glutamate and Neurodegenerative Disease.- Modulation of the Kynurenine Pathway for the Potential Treatment of Neurodegenerative Diseases.- Spinal Muscular Atrophy: Current Therapeutic Strategies
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemistry.
Topical term or geographic name as entry element Toxicology.
Topical term or geographic name as entry element Biochemistry.
Topical term or geographic name as entry element Neurology.
Topical term or geographic name as entry element Chemistry.
Topical term or geographic name as entry element Medicinal Chemistry.
Topical term or geographic name as entry element Neurology.
Topical term or geographic name as entry element Pharmacology/Toxicology.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9783642167577
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-3-642-16758-4
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-14AUM Main Library2014-04-14 2014-04-14 E-Book   AUM Main Library615.19